Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Copaxone's Effect on MRI-Monitored Disease in Relapsing MS is Reproducible and Sustained
Neurol 59:1284-1286, Wolinsky,J.S.,et al, 2002
Fragile X Premutation Carriers: Characteristic MR Imaging Findings of Adult Male Patients with Progressive Cerebellar and Cognitive Dysfunction.
AJNR 23:1757-1766, Brunberg,J.A.,et al, 2002
Mycoplasma Pneumoniae Encephalitis in Childhood
J Microbiol Immunol Infect 35:173-178, Lin,W.-C., et al, 2002
Obturator Neuropathy: Causes and Outcome
Muscle Nerve 25:605-607, Sorenson,E.,et al, 2002
Subacute Sclerosing Panencephalitis Clinical and Magnetic Resonance Imaging Evaluation of 36 Patients
J Child Neurol 17:25-29, Ozturk, A.,et al, 2002
Temporal Arteritis and Guillain-Barr� Syndrome
South Med J 95:1081-1082, Roca,B.,et al, 2002
Glutamic Acid Decarboxylase Autoantibodies and Neurological Disorders
Neurol Sci 23:145-151, Vianello,M.,et al, 2002
Safety of HMG-CoA Reductase Inhibitors: Focus on Atorvastatin
Cardiovasc Drugs Ther 15:211-218, Bernini,F.,et al, 2001
Alcohol Related Neuropathy
Diagnosis and Management of Peripheral Nerve Disorders :332, Mendell,J.R.,et al, 2001
The Effect of IFNB-1b on the Evolution of Enhancing Lesions in Secondary Progressive MS
Neurol 57:2185-2190, Brex,P.A.,et al, 2001
Nemaline Myopathy:A Clinical Study of 143 Cases
Ann Neurol 50:312-320, Ryan,M.M.,et al, 2001
Nonpoliovirus Poliomyelitis Simulating Guillain-Barre Syndrome
Arch Neurol 58:1460-1464, Gorson,K.C.&Ropper,A.H., 2001
Clinical and Genetic Aspects of Distal Myopathies
Muscle Nerve 24:1440-1450, Saperstein,D.S.,et al, 2001
Amyotrophic Lateral Sclerosis
NEJM 344:1688-1700, Rowland,L.P. & Shneider,N.A., 2001
Effect of Early Interferon Treatment on Conversion to Definite Multiple Sclerosis: A Randomised Study
Lancet 357:1576-1582,1547, Comi,G.,et al, 2001
Radial Entrapment Neuropathy Due to Chronic Injection-induced Triceps Fibrosis
Muscle Nerve 24:134-137, Midroni,G. & Moulton,R., 2001
Association Between Migraine and Endothelin Type A Receptor (ETA-231 A/G) Gene Polymorphism
Neurol 56 :1273-1277, Tzourio,C.,et al, 2001
Fulminant Liver Failure During Interferon Beta Treatment of Multiple Sclerosis
Neurol 56:1416, Yoshida,E.M.,et al, 2001
An Epidemic of Arsenic Neuropathy From a Spiked Curry
Neurol 56:1417-1418, Kishi,Y.,et al, 2001
The Outbreak of West Nile Virus Infection in the New York City Area in 1999
NEJM 344:1807-1814,1858, Nash,D.,et al, 2001
Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1496-1504, Secondary Progressive Efficacy Clinical Trial of R, 2001
Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1505-1513, Li,D.K.B.,et al, 2001
Anticipating Mechanical Ventilation in Guillain-Barre Syndrome
Arch Neurol 58:893-898,871, Lawn,N.D.,et al, 2001
Early Electrodiagnostic Findings in Guillain-Barre Syndrome
Arch Neurol 58:913-917, Gordon,P.H. & Wilbourn,A.J., 2001
Diagnosis of X-Linked Myotubular Myopathy by Detection of Myotubularin
Ann Neurol 50:42-46, Laporte,J.,et al, 2001
Predominant Involvement of a Particular Group of Fingers Due to Small, Cortical Infarction
Neurol 56:1677-1682, Kim,J.S., 2001
Focal Myopathy Mimicking Posterior Interosseous Nerve Syndrome
Muscle Nerve 24:969-972, Erdem,S.,et al, 2001
Clinical Study of 222 Patients with Pure Motor Stroke
JNNP 71:239-242, Arboix,A.,et al, 2001
Mild Guillain-Barre Syndrome
Arch Neurol 58:1098-1101, Green,D.M. &Ropper,A.H., 2001
Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease
NEJM 345:85-92, Klempner,M.S.,et al, 2001
PRISMS-4: Long-Term Efficacy of Interferon-B-1a in Relapsing MS
Neurol 56:1628-1636,1620, The PRISMS Study Group, 2001
Open-Label Dose-Titration Safety and Efficacy Study of Tizanidine Hydrocholoride in the Treatment of Spasticity Associated With Chronic Stroke
Stroke 32:1841-1846, Gelber,D.A.,et al, 2001
Measurement of Antibodies to Interferon Beta in Patients With Multiple Sclerosis
Arch Neurol 58:1299-1300,1301, Pachner,A.R., 2001
The Significance of Neutralizing Antibodies in Patients With Multiple Sclerosis Treated With Interferon Beta
Arch Neurol 58:1297-1298,1301, Rice,G., 2001
Inclusiong Body Myositis Mimicking Motor Neuron Disease
Arch Neurol 58:1253-1256, Dabby,R.,et al, 2001
The Neurologic Complications of Scleromyxedema
Medicine 80:313-319, Berger,J.R.,et al, 2001
Transient Ischemic Attack and Stroke Associated with Sildenafil (Viagra) Use
Neurol 57:1730-1731, Morgan,J.C.,et al, 2001
A Diffusion-Weighted MRI Study of Acute Ischemic Distal Arm Paresis
Neurol 57:1589-1594, Gass,A.,et al, 2001
Mitochondrial Disease and Stroke
Stroke 32:2507-2510, Martinez-Fernandez,E.,et al, 2001
Neurology of Ciguatera
JNNP 70:4-8, Pearn,J., 2001
Collateral Ability of the Circle of Willis in Patients With Unilateral Internal Carotid Artery Occlusion
Stroke 32:2768-2773, Hendrikse,J.,et al, 2001
Botulinum Toxin Type A in Primary Palmar Hyperhidrosis
Neurol 57:2095-2099, Saadia,D.,et al, 2001
Oculopharyngeal Muscular Dystrophy in Hispanic New Mexicans
JAMA 286:2437-2440, Becher,M.W.,et al, 2001
Spinocerebellar Ataxia Type 2 Presenting as Familial Levodopa-Responsive Parkinsonism
Ann Neurol 50:812-815, Shan,D.,et al, 2001
Clinicopath Conf,Systemic Sclerosis with Scleroderma Renal Crisis
NEJM 345:596-605, Case 26-2001, 2001
A 47-Year-Old Woman with Tension-Type Headaches
JAMA 286:960-966, Welch,K.M.A., 2001
Guillain-Barre Syndrome Complicated with Hemolytic Anemia in Association with Antiganglioside GM3 Antibody
Am J Med 110:399-400, Aoyama,K.,et al, 2001
Clinicopath Conf, Strychnine Poisoning, Case 12-2001
NEJM 344:1232-1239, , 2001
European/Canadian Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Effects of Glatiramer Acetate on Magnetic Resonance Imaging-Measured Disease Activity and Burden in Patients wi
Ann Neurol 49:290-297, Comi,G.,et al, 2001